Loading data
AVBPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 153.35 m USD | 79 m USD | 64.88 m USD |
| Operating profit | -177.53 m USD | -94.31 m USD | -74.59 m USD |
| Net income (reported basis) | -166.31 m USD | -80.49 m USD | -69.33 m USD |
| Net income attributable to common shareholders | -166.31 m USD | -80.49 m USD | -69.33 m USD |
| Basic earnings per share | -4.32 USD/share | -2.56 USD/share | -32.38 USD/share |
| Diluted earnings per share | -4.32 USD/share | -2.56 USD/share | -32.38 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.